Open AccessHYDROXYCHLOROQUINE BLOOD LEVELS IN STABLE LUPUS NEPHRITIS UNDER VERY LOW-DOSE HCQ REGIMEN (2-3 mg/Kg/day): 12-MONTHS PROSPECTIVE RANDOMIZED CONTROLLED TRIAL
Author(s) -
Caio Bosquiero Zanetti,
Sandra Gofinet Pasoto,
Clóvis A. Silva,
Eloísa Bonfá,
Tatiana do Nascimento Pedrosa,
Léonard de Vinci Kanda Kupa,
Nádia Emi Aikawa,
Eduardo Ferreira Borba,
Margarete Borges Galhardo Vendramini
Publication year - 2021
Publication title -
anais do congresso brasileiro de reumatologia 2020
Language(s) - English
Resource type - Conference proceedings
DOI - 10.47660/cbr.2020.17237
Subject(s) - hydroxychloroquine , medicine , regimen , randomized controlled trial , lupus nephritis , covid-19 , disease , infectious disease (medical specialty)